|
|
|
| home > white papers > Financial implications of off-site visits in clinical research, perception versus reality - Illingworth Research |
|
|
 WHITE PAPERS |
|
Illingworth Research
|
|
Financial implications of off-site visits in clinical research, perception versus reality
|
|
The concept of patient centricity is still relatively new within
clinical trials. For too long, the most important person in the trial
has been overlooked… the patient. Here, we explore the benefits of
conducting a more patient-centric trial for the patient, site and
sponsor through mobile, or ‘off -site’ visits. These advantages are much
greater than purely financial, although the financial implications of
running a more patient-focused clinical trial may previously have
deterred some from this approach. Home nursing in clinical trials
continues to be thought of as a high value “premium” service, which many
sponsors decline in an attempt to remain within budget for the trial.
However, is the actual cost of off -site nursing more expensive than the
traditional site model?
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Coave Therapeutics to Present Data on its Chemically Engineered AAV Vectors for Gene Therapy in CNS Disease at ASCGT
Paris, France, 4th May 2022 - Coave Therapeutics (‘Coave’), a
clinical-stage biotechnology company focused on developing life-changing
gene therapies for CNS (Central Nervous System) and eye diseases, today
announced that research on its AAV-Ligand Conjugates platform
(ALIGATER) will be presented at the 2022 American Society of Cell &
Gene Therapy (ASCGT) meeting, which will be held virtually and in person
in Washington, D.C., 16 to 19 May.
More info >> |
|
 |
White Papers |
 |
|
Pandemic respiratory vaccine clinical trials: a departure from business as usual
ICON plc
Around the world, the “V” words are on everyone’s lips: Virus and Vaccines. In response to the urgent need for a vaccine for COVID-19, researchers are, at time of publication, running 500+ clinical trials (and counting) on a number of antivirals, antibodies and vaccines. Promising possibilities range from novel new drugs/vaccines, repurposing treatments currently indicated for HIV, Ebola and malaria, to monoclonal antibodies and immune serum.
More info >> |
|
 |
Industry Events |
 |
Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022)
20-21 June 2022, Berlin, Germany
Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) is
held on June, 20-21, 2022 in Berlin, Germany. The Congress gathers
pharmaceutical companies, CMOs and CDMOs, governmental bodies together
with pharmaceutical equipment providers and service companies to discuss
the manufacturing and packaging processes of the pharmaceutical
industry. Among the participating companies are Bayer, Sandoz, Merck,
Novartis, Roche, Genveon, Samsung Biologics, Pfizer.
More info >> |
|
|
|
